This compound is a pharmaceutical intermediate specifically used in the manufacturing of ibrutinib. It is a pyrazolopyrimidine derivative with a tert-butyl carbamate protecting group and contains an ether-linked phenoxyphenyl substituent.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1022150-11-3
Ibrutinib acetyl impurity
pharmaceutical impurity standard
PCI-32765 (Racemate)
pharmaceutical raw material
Ibrutinib
pharmaceutical raw material
Lomifylline
pharmaceutical raw material
Glyburide
pharmaceutical raw material
Difelikefalin
pharmaceutical raw material
Difelikefalin acetate
pharmaceutical raw material
Tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
research reagent
tert-butyl (3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate
NTSAEGNFPKKRLX-LJQANCHMSA-N
CC(C)(C)OC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
—